Treatment Adherence Disparities and Clinical Outcomes of Osimertinib among Ethnic-Minority Patients with EGFR-Mutated NSCLC

被引：0
|
作者：
Lee, M. [1 ]
Miao, E. [2 ]
Zhang, C. [2 ]
Xue, X. [2 ]
Tuckman, S. [3 ]
Halmos, B. [1 ]
Cheng, H. [1 ]
机构：
[1] Montefiore Einstein Canc Ctr MECC, Bronx, NY USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Bronx, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Osimertinib adherence; NSCLC; Socioeconomic healthcare; disparities;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-04
引用
收藏
页码：S331 / S332
页数：2
相关论文
共 50 条
  • [31] Clinical outcomes of patients with EGFR-mutated NSCLC developing interstitial lung disease during first-line osimertinib therapy: a sub-analysis of the Reiwa study
    Kobayashi, Takayuki
    Watanabe, Kageaki
    Hosomi, Yukio
    Yoh, Kiyotaka
    Usui, Kazuhiro
    Kishi, Kazuma
    Naka, Go
    Tamano, Shu
    Uemura, Kohei
    Kunitoh, Hideo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
  • [32] Patient Reports from ADAURA: HRQol Data on Osimertinib as adjuvant Therapy in Patients with resected EGFR-mutated (EGFRm) NSCLC
    Engel-Riedel, W.
    Majem, M.
    Goldman, J. W.
    Grohe, C.
    John, T.
    Laktionov, K.
    Kim, S.
    Kato, T.
    Vu, H. V.
    Lu, S.
    Lee, K.
    Akewanlop, C.
    Yu, C. J.
    de Marinis, F.
    Bonanno, L.
    Domine, M.
    Shepherd, F. A.
    Zeng, L.
    Kulkarni, D.
    Medic, N.
    Tsuboi, M.
    Herbst, R. S.
    Wu, Y. L.
    Wohlleber, M.
    PNEUMOLOGIE, 2021, 75 : S21 - S21
  • [33] Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients
    Perng, Pang-Shuo
    Hsu, Heng-Juei
    Lee, Jung-Shun
    Wang, Liang-Chao
    Huang, Chih-Yuan
    Tien, Chih-Hao
    Lai, Yu-Hsuan
    Su, Po-Lan
    Hsu, Hao-Hsiang
    Chen, Liang-Yi
    Lee, Po-Hsuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [34] Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies
    Li, Li
    Huang, Qin
    Sun, Jianhai
    Yan, Fei
    Wei, Wujie
    Li, Zihui
    Liu, Li
    Deng, Jie
    ACTA ONCOLOGICA, 2022, 61 (11) : 1347 - 1353
  • [35] Matched Targeted Therapy by cfDNA of CSF Beyond Leptomeningeal Metastases Progression Upon Osimertinib in EGFR-Mutated NSCLC Patients
    Zheng, M.
    Li, Y.
    Tu, H.
    Sun, H.
    Yin, K.
    Yang, J.
    Zhang, X.
    Zhou, Q.
    Wu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S877 - S877
  • [36] Outcomes of surgery and subsequent therapy for central nervous system oligoprogression in EGFR-mutated NSCLC patients
    Pang-Shuo Perng
    Heng-Juei Hsu
    Jung-Shun Lee
    Liang-Chao Wang
    Chih-Yuan Huang
    Chih-Hao Tien
    Yu-Hsuan Lai
    Po-Lan Su
    Hao-Hsiang Hsu
    Liang-Yi Chen
    Po-Hsuan Lee
    World Journal of Surgical Oncology, 21
  • [37] Clinical Outcomes of Patients with EGFR T790M+NSCLC on Osimertinib
    Tan, W. L.
    Hennedige, T. P.
    Ng, Q. S.
    Tan, S. H.
    Tran, N. T. A.
    Chua, B. J. G.
    Toh, C. K.
    Tan, E. H.
    Tan, D.
    Ang, M.
    Kanesvaran, R.
    Jain, A.
    Lim, T. K. H.
    Gogna, A.
    Koh, M.
    Yip, C. S. P.
    Thng, C. H.
    Chowbay, B.
    Tan, M. H.
    Lim, W.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2206 - S2206
  • [38] Survival disparities among African American (AA) patients (pts) with EGFR-mutated non-small cell lung cancer (NSCLC).
    Cheng, Haiying
    Hosgood, H. Dean
    Ye, Qian
    Sharma, Janaki Neela
    Su, Christopher
    Halmos, Balazs
    Perez-Soler, Roman
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [39] Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC
    Saw, Stephanie P. L.
    Low, Yi Fen
    Lai, Gillianne G. Y.
    Chan, Landon L.
    Wong, Wesley K. Y.
    Tsui, Giselle
    Chen, Olivia H.
    Seet, Amanda O. L.
    Tan, Wei Chong
    Tan, Aaron C.
    Chan, Johan W. K.
    Teh, Yi Lin
    Tan, Wan -Ling
    Ng, Quan Sing
    Ang, Mei-Kim
    Kanesvaran, Ravindran
    Lim, Darren W. T.
    Tan, Daniel S. W.
    Mok, Tony S. K.
    Li, Molly S. C.
    LUNG CANCER, 2024, 193
  • [40] Real-world outcomes of pemetrexed-platinum chemotherapy plus osimertinib after progression on first-line osimertinib in advanced EGFR-mutated NSCLC
    Saw, Stephanie Pei Li
    Low, Yi Fen
    Lai, Gillianne
    Chan, Landon
    Wong, Wesley K. Y.
    Tsui, Giselle
    Chen, Olivia
    Seet, Amanda Oon Lim
    Tan, Wei Chong
    Tan, Aaron C.
    Chan, Johan W. K.
    Teh, Yi Lin
    Tan, Wan Ling
    Ng, Quan Sing
    Ang, Mei-Kim
    Kanesvaran, Ravindran
    Lim, Darren Wan-Teck
    Tan, Daniel Shao-Weng
    Mok, Tony S. K.
    Li, Molly Sc
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345